Psoriasis News and Research

Latest Psoriasis News and Research

Investigating the impact of COVID-19 vaccinations in immunocompromised adult patients

Investigating the impact of COVID-19 vaccinations in immunocompromised adult patients

Exploring the immunomodulatory and anti-inflammatory properties of butyrate

Exploring the immunomodulatory and anti-inflammatory properties of butyrate

Skin medication shows promise in treating alcohol use disorder

Skin medication shows promise in treating alcohol use disorder

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

Cardiovascular risk in psoriasis, the association between psoriatic inflammation and atherosclerosis, and the cardiovascular-risk-reducing effects of biologics

Cardiovascular risk in psoriasis, the association between psoriatic inflammation and atherosclerosis, and the cardiovascular-risk-reducing effects of biologics

COVID-19 might increase risk of autoimmune diseases

COVID-19 might increase risk of autoimmune diseases

Doctoral research presents predictive value of biomarkers for inflammatory bowel diseases

Doctoral research presents predictive value of biomarkers for inflammatory bowel diseases

Scientists make breakthrough in understanding how inflammation is regulated

Scientists make breakthrough in understanding how inflammation is regulated

Extraordinary plasticity of the glucocorticoid receptor revealed

Extraordinary plasticity of the glucocorticoid receptor revealed

TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes

TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes

Multiple research platforms identify environmental chemical agents that promote intestinal inflammation

Multiple research platforms identify environmental chemical agents that promote intestinal inflammation

Does skin inflammation exacerbate COVID-19?

Does skin inflammation exacerbate COVID-19?

People with end-stage renal disease and psoriasis do not have increased risk for heart attack

People with end-stage renal disease and psoriasis do not have increased risk for heart attack

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Immune-mediated inflammatory diseases following COVID-19

Immune-mediated inflammatory diseases following COVID-19

Thirdhand smoke exposure elevates biomarkers associated with the initiation of skin diseases

Thirdhand smoke exposure elevates biomarkers associated with the initiation of skin diseases

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Studies explore how differences in skin composition may lead to dermatological conditions

Studies explore how differences in skin composition may lead to dermatological conditions

Patients with autoimmune diseases at greater risk of complications after heart attack

Patients with autoimmune diseases at greater risk of complications after heart attack

People with autoimmune disorder have a higher risk of developing cardiovascular disease

People with autoimmune disorder have a higher risk of developing cardiovascular disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.